Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]
Specified Drug-Use Survey on Entyvio for IV Infusion 300 mg [Crohn's Disease]
Crohn's disease
Intervention name : Vedolizumab (Genetical Recombination) INN of the intervention : Vedolizumab Dosage And administration of the intervention : Vedolizumab (Genetical Recombination) 300 milligrams (mg), intravenous (IV) infusion, at Weeks 0, 2 and 6, and every 8 weeks thereafter, for up to 54 weeks. Participants will receive IV infusion as part of routine medical care. Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : - Intervention name : Vedolizumab (Genetical Recombination) INN of the intervention : Vedolizumab Dosage ...